Aspirin, beta-blocker and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction

By Berger A.K.   Duval S.   Krumholz H.M.  

ACC Current Journal Review, Vol. 12, Iss. 5, 2003-09 ,pp. : 17-17

Elsevier

Access to resources Recommend Favorite

Angiotensin-converting enzyme (ACE) inhibitor therapy after myocardial infarction in relation to left ventricular function

By Reikvam Aasmund   Kvan Elena   Landmark Knud   Aursnes Ivar  

Scandinavian Cardiovascular Journal, Vol. 37, Iss. 3, 2003-01 ,pp. : 130-134

Informa Healthcare

Access to resources Recommend Favorite

The effect of high plasma levels of angiotensin-converting enzyme (ACE) and plasminogen activator inhibitor (PAI-1) on the reperfusion after thrombolytic therapy in patients presented with acute myocardial infarction

By Menyar Ayman   Altamimi O.   Gomaa Mohamed   Fawzy Zainab   Rahman M.   Bener Abdulbari  

Journal of Thrombosis and Thrombolysis, Vol. 21, Iss. 3, 2006-06 ,pp. : 235-240

Springer Publishing Company

Access to resources Recommend Favorite

The appropriate dose of angiotensin‐converting‐enzyme inhibitors or angiotensin receptor blockers in patients with dilated cardiomyopathy. The higher, the better?

By  

ESC HEART FAILURE, Vol. 2, Iss. 4, 2015-12 ,pp. : 103-105

John Wiley & Sons Inc

Access to resources Recommend Favorite

Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the Treatment of Hypertension: Should they be Used Together?

By  

Current Vascular Pharmacology, Vol. 8, Iss. 6, 2010-11 ,pp. : 742-746

Bentham Science Publishers

Access to resources Recommend Favorite